Challenges and recommendations for the health-economic evaluation of primary prevention programmes for dementia

References

• van Baal, P. H. M., Hoogendoorn, M., & Fischer, A. (2016). Preventing dementia by promoting physical activity and the long-term impact on health and social care expenditures. Preventive Medicine, 85, 78–83. http://doi.org/10.1016/j.ypmed.2016.01.013
   PubMed Web of Science ®Google Scholar
• CEA. (2017). Cost-effectiveness analysis registry. Retrieved from http://healtheconomics.tuftsmedicalcenter.org/cear4/SearchingtheCEARegistry/SearchtheCEARegistry.aspx
   Google Scholar
• Comas-Herrera, A., Knapp, M., Wittenberg, R., Banerjee, S., Bowling, A., Grundy, E., … MODEM Project group. (2017). MODEM: A comprehensive approach to modelling outcome and costs impacts of interventions for dementia. Protocol paper. BMC Health Services Research, 17(1), 25. http://doi.org/10.1186/s12913-016-1945-x
   PubMedGoogle Scholar
• CRD. (2017). Centre for review and dissemination database. Retrieved from https://www.crd.york.ac.uk/CRDWeb/
   Google Scholar
• Davis, J. C., Bryan, S., Marra, C. A., Hsiung, G.-Y. R., & Liu-Ambrose, T. (2015). Challenges with cost-utility analyses of behavioural interventions among older adults at risk for dementia. British Journal of Sports Medicine, 49(20), 1343–1347. http://doi.org/10.1136/bjsports-2013-092743
   PubMed Web of Science ®Google Scholar
• Deckers, K., van Boxtel, M. P. J., Schiepers, O. J. G., de Vugt, M., Muñoz Sánchez, J. L., Anstey, K. J., … Köhler, S. (2015). Target risk factors for dementia prevention: A systematic review and Delphi consensus study on the evidence from observational studies. International Journal of Geriatric Psychiatry, 30(3), 234–246. http://doi.org/10.1002/gps.4245
   PubMed Web of Science ®Google Scholar
• Fowler, N. R., Morrow, L. A., Tu, L.-C., Landsittel, D. P., Snitz, B. E., Rodriquez, E. G., & Saxton, J. A. (2012). Association between cognitive decline in older adults and use of primary care physician services in Pennsylvania. Journal of Primary Care & Community Health, 3(3), 201–209. http://doi.org/10.1177/2150131911434204
   PubMedGoogle Scholar
• Gustavsson, A., Green, C., Jones, R. W., Förstl, H., Simsek, D., de Reydet de Vulpillieres, F., … Wimo, A. (2017). Current issues and future research priorities for health economic modelling across the full continuum of Alzheimer's disease. Alzheimer's & Dementia, 13(3), 312–321. http://doi.org/10.1016/j.jalz.2016.12.005
   PubMed Web of Science ®Google Scholar
• Handels, R. L. H., Joore, M. A., Tran-Duy, A., Wimo, A., Wolfs, C. A. G., Verhey, F. R. J., & Severens, J. L. (2015). Early cost-utility analysis of general and cerebrospinal fluid-specific Alzheimer's disease biomarkers for hypothetical disease-modifying treatment decision in mild cognitive impairment. Alzheimer's & Dementia : The Journal of the Alzheimer's Association, 11(8), 896–905. http://doi.org/10.1016/j.jalz.2015.02.009
   PubMed Web of Science ®Google Scholar
• Husereau, D., Drummond, M., Petrou, S., Carswell, C., Moher, D., Greenberg, D., … Loder, E. (2013). Consolidated health economic evaluation reporting standards (CHEERS) statement. European Journal of Health Economics, 14(3), 367–372. http://doi.org/10.1007/s10198-013-0471-6
   PubMed Web of Science ®Google Scholar
• Imtiaz, B., Tolppanen, A.-M., Kivipelto, M., & Soininen, H. (2014). Future directions in Alzheimer's disease from risk factors to prevention. Biochemical Pharmacology, 88(4), 661–670. http://doi.org/10.1016/j.bcp.2014.01.003
   PubMed Web of Science ®Google Scholar
• Jönsson, L., Andreasen, N., Kilander, L., Soininen, H., Waldemar, G., Nygaard, H., … Wimo, A. (2006). Patient- and proxy-reported utility in Alzheimer disease using the EuroQoL. Alzheimer Disease and Associated Disorders, 20(1), 49–55. http://doi.org/10.1097/01.wad.0000201851.52707.c9
   PubMed Web of Science ®Google Scholar
• Kivipelto, M., Ngandu, T., Laatikainen, T., Winblad, B., Soininen, H., & Tuomilehto, J. (2006). Risk score for the prediction of dementia risk in 20 years among middle aged people: A longitudinal, population-based study. The Lancet. Neurology, 5(9), 735–741. http://doi.org/10.1016/S1474-4422(06)70537-3
   PubMed Web of Science ®Google Scholar
• Koopmanschap, M. A., van Exel, J. N. A., van den Berg, B., & Brouwer, W. B. F. (2008). An overview of methods and applications to value informal care in economic evaluations of healthcare. PharmacoEconomics, 26(4), 269–280.
   PubMed Web of Science ®Google Scholar
• Leibson, C. L., Long, K. H., Ransom, J. E., Roberts, R. O., Hass, S. L., Duhig, A. M., … Petersen, R. C. (2015). Direct medical costs and source of cost differences across the spectrum of cognitive decline: A population-based study. Alzheimer's & Dementia : The Journal of the Alzheimer's Association, 11(8), 917–932. http://doi.org/10.1016/j.jalz.2015.01.007
   PubMed Web of Science ®Google Scholar
• Lin, P.-J., Yang, Z., Fillit, H. M., Cohen, J. T., & Neumann, P. J. (2014). Unintended benefits: The potential economic impact of addressing risk factors to prevent Alzheimer's disease. Health Affairs (Project Hope), 33(4), 547–554. http://doi.org/10.1377/hlthaff.2013.1276
   PubMed Web of Science ®Google Scholar
• MODEM. (2017). MODEM dementia toolkit. Retrieved from toolkit.modem-dementia.org.uk/database
   Google Scholar
• Ngandu, T., Lehtisalo, J., Solomon, A., Levälahti, E., Ahtiluoto, S., Antikainen, R., … Kivipelto, M. (2015). A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): A randomised controlled trial. Lancet (London, England), 385(9984), 2255–2263. http://doi.org/10.1016/S0140-6736(15)60461-5
   PubMed Web of Science ®Google Scholar
• Prince, M., Albanese, E., Guerchet, M., & Prina, M. (2014). World Alzheimer Report 2014. Retrieved from https://www.alz.co.uk/research/WorldAlzheimerReport2014.pdf
   Google Scholar
• Prince, M., Guerchet, M., & Prina, M. (2015). The epidemiology and impact of dementia: Current state and future trends. Geneva: World Health Organization. Retrieved fromhttp://www.who.int/mental_health/neurology/dementia/dementia_thematicbrief_epidemiology.pdf
   Google Scholar
• Prince, M., Wimo, A., Guerchet, M., Ali, G., WU, Y., & Prina, M. (2015). World Alzheimer Report 2015 The Global Impact of Dementia. London: Alzheimer's Disease International. Retrieved from https://www.alz.co.uk/research/WorldAlzheimerReport2015.pdf
   Google Scholar
• Richard, E., Jongstra, S., Soininen, H., Brayne, C., Moll van Charante, E. P., Meiller, Y., … Andrieu, S. (2016). Healthy ageing through internet counselling in the elderly: The HATICE randomised controlled trial for the prevention of cardiovascular disease and cognitive impairment. BMJ Open, 6(6), e010806. http://doi.org/10.1136/bmjopen-2015-010806
   PubMed Web of Science ®Google Scholar
• Sano, M., Zhu, C. W., Whitehouse, P. J., Edland, S., Jin, S., Ernstrom, K., … Alzheimer Disease Cooperative Study Group. (2006). ADCS prevention instrument project: Pharmacoeconomics: Assessing health-related resource use among healthy elderly. Alzheimer Disease and Associated Disorders, 20(4 Suppl 3), S191–S202. http://doi.org/10.1097/01.wad.0000213875.63171.87
   PubMed Web of Science ®Google Scholar
• Sköldunger, A., Johnell, K., Winblad, B., & Wimo, A. (2013). Mortality and treatment costs have a great impact on the cost-effectiveness of disease modifying drugs in Alzheimer's disease. Current Alzheimer Research, 10(2), 207–216.
   PubMed Web of Science ®Google Scholar
• van Charante, E. P. M., Richard, E., Eurelings, L. S., van Dalen, J.-W., Ligthart, S. A., van Bussel, E. F., … van Gool, W. A. (2016). Effectiveness of a 6-year multidomain vascular care intervention to prevent dementia (preDIVA): A cluster-randomised controlled trial. Lancet (London, England), 388(10046) 797–805. http://doi.org/10.1016/S0140-6736(16)30950-3
   PubMed Web of Science ®Google Scholar
• Van Rossum, I. A., Vos, S., Handels, R., & Visser, P. J. (2010). Biomarkers as predictors for conversion from mild cognitive impairment to Alzheimer-type dementia: Implications for trial design. Journal of Alzheimers Disease JAD, 20(3), 881–891. http://doi.org/10.3233/JAD-2010-091606
   PubMed Web of Science ®Google Scholar
• Vellas, B., Carrie, I., Gillette-Guyonnet, S., Touchon, J., Dantoine, T., Dartigues, J. F., … Andrieu, S. (2014). Mapt study: A multidomain approach for preventing Alzheimer's disease: Design and baseline data. The Journal of Prevention of Alzheimer's Disease, 1(1), 13–22.
   PubMedGoogle Scholar
• World Health Organization. (2012). Dementia: A public health priority. Geneva: World Health Organization & Alzheimer Disease International. Retrieved fromhttp://apps.who.int/iris/bitstream/10665/75263/1/9789241564458_eng.pdf
   Google Scholar
• World Health Organization. (2015). First WHO ministerial conference on global action against dementia. Retrieved fromhttp://apps.who.int/iris/bitstream/10665/179537/1/9789241509114_eng.pdf
   Google Scholar
• Wimo, A., Ballard, C., Brayne, C., Gauthier, S., Handels, R., Jones, R. W., … Kramberger, M. (2014). Health economic evaluation of treatments for Alzheimer's disease: Impact of new diagnostic criteria. Journal of Internal Medicine, 275(3), 304–316. http://doi.org/10.1111/joim.12167
   PubMed Web of Science ®Google Scholar
• Wimo, A., Gustavsson, A., Jönsson, L., Winblad, B., Hsu, M.-A., & Gannon, B. (2013). Application of resource utilization in dementia (RUD) instrument in a global setting. Alzheimer's & Dementia, 9(4), 429–435.e17. http://doi.org/10.1016/j.jalz.2012.06.008
   PubMed Web of Science ®Google Scholar
• Wimo, A., Jönsson, L., Bond, J., Prince, M., & Winblad, B. (2013). The worldwide economic impact of dementia 2010. Alzheimers Dementia: The Journal of the Alzheimers Association, 9, 1–11.e3. http://doi.org/10.1016/j.jalz.2012.11.006
   PubMed Web of Science ®Google Scholar
• Winblad, B., Amouyel, P., Andrieu, S., Ballard, C., Brayne, C., Brodaty, H., … Zetterberg, H. (2016). Defeating Alzheimer's disease and other dementias: A priority for European science and society. The Lancet. Neurology, 15(5), 455–532. http://doi.org/10.1016/S1474-4422(16)00062-4
   PubMed Web of Science ®Google Scholar
• Yang, Z., Zhang, K., Lin, P.-J., Clevenger, C., & Atherly, A. (2012). A longitudinal analysis of the lifetime cost of dementia. Health Services Research, 47(4), 1660–1678. http://doi.org/10.1111/j.1475-6773.2011.01365.x
   PubMed Web of Science ®Google Scholar
• Zhang, Y., Kivipelto, M., Solomon, A., & Wimo, A. (2011). Cost-effectiveness of a health intervention program with risk reductions for getting demented: Results of a Markov model in a Swedish/Finnish setting. Journal of Alzheimer's Disease: JAD, 26(4), 735–744. http://doi.org/10.3233/JAD-2011-110065
   PubMed Web of Science ®Google Scholar